Schonfeld Strategic Advisors LLC - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 92 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q2 2020$1,972,000
+661.4%
19,302
+704.2%
0.03%
+62.5%
Q1 2020$259,000
-95.0%
2,400
-95.6%
0.02%
-91.4%
Q2 2019$5,222,00054,7970.18%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q3 2019
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders